EVERSANA REIGNITE Trademark

Trademark Overview

On Thursday, April 28, 2022, a trademark application was filed for EVERSANA REIGNITE with the United States Patent and Trademark Office. The USPTO has given the EVERSANA REIGNITE trademark a serial number of 97386593. The federal status of this trademark filing is EX PARTE APPEAL PENDING as of Monday, March 25, 2024. This trademark is owned by EVERSANA LIFE SCIENCE SERVICES, LLC. The EVERSANA REIGNITE trademark is filed in the Advertising, Business and Retail Services category with the following description:

Assistance in business management and product commercialization for biopharma companies to maximize product value and optimize revenue at the late stages of the product life cycle
eversana reignite

General Information

Serial Number97386593
Word MarkEVERSANA REIGNITE
Filing DateThursday, April 28, 2022
Status760 - EX PARTE APPEAL PENDING
Status DateMonday, March 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesAssistance in business management and product commercialization for biopharma companies to maximize product value and optimize revenue at the late stages of the product life cycle

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, May 3, 2022
Primary Code035
First Use Anywhere DateSaturday, January 1, 2022
First Use In Commerce DateSaturday, January 1, 2022

Trademark Owner History

Party NameEVERSANA LIFE SCIENCE SERVICES, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMILWAUKEE, WI 53202

Trademark Events

Event DateEvent Description
Tuesday, March 12, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, January 9, 2024NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Tuesday, January 9, 2024ACTION DENYING REQ FOR RECON E-MAILED
Tuesday, January 9, 2024ACTION CONTINUING FINAL - COMPLETED
Thursday, December 21, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, December 21, 2023EX PARTE APPEAL-INSTITUTED
Thursday, December 21, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, December 21, 2023EXPARTE APPEAL RECEIVED AT TTAB
Thursday, September 7, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, September 7, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, June 21, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, June 21, 2023FINAL REFUSAL E-MAILED
Wednesday, June 21, 2023FINAL REFUSAL WRITTEN
Thursday, May 18, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 17, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 17, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 21, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 21, 2023NON-FINAL ACTION E-MAILED
Tuesday, February 21, 2023NON-FINAL ACTION WRITTEN
Wednesday, February 15, 2023ASSIGNED TO EXAMINER
Tuesday, May 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 2, 2022NEW APPLICATION ENTERED

Related Keywords

reignite eversana product revenue optimize late stages life value cycle maximize management